Organ-on-chip technologies at the cancer-thrombosis interface

Area of Science:

• Biomedical Engineering
• Oncology
• Hematology

Background:

• Cancer-associated thrombosis (CAT) is a significant cause of mortality in cancer patients.
• Tumour-haemostasis interactions are the primary drivers of CAT.
• Traditional research models struggle to fully replicate the complexity of CAT.

Purpose of the Study:

• To explore the potential of organ-on-chip (OoC) technology in studying cancer-associated thrombosis.
• To enhance the understanding of the mechanisms underlying CAT.
• To identify new therapeutic strategies for managing CAT.

Main Methods:

• Utilizing organ-on-chip models to simulate tumour-haemostasis interactions.
• Investigating the biological processes involved in CAT within the OoC environment.
• Analyzing the efficacy of potential therapeutic interventions using OoC platforms.

Main Results:

• OoC models provide a more complex and accurate representation of tumour-haemostasis interactions compared to traditional methods.
• The study elucidated key mechanisms driving cancer-associated thrombosis.
• Preliminary data suggests potential for OoC in evaluating novel CAT therapies.

Conclusions:

• Organ-on-chip technology presents a promising platform for advancing the study of cancer-associated thrombosis.
• OoC offers enhanced insights into CAT mechanisms, paving the way for improved therapeutic strategies.
• This approach holds potential for personalized medicine in oncology and hematology.